SMXT, ANVS and IFBD among pre-market losers

seekingalpha2024-02-28

Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2414432421?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-02-28 21:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2414432421","market":"us","top_or_hot":-1,"title":"SMXT, ANVS and IFBD among pre-market losers","media":"seekingalpha","content":"<div>\n<p>Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. ...</p>\n\n<a href=\"https://seekingalpha.com/news/4072977-smxt-anvs-and-ifbd-among-pre-market-losers\">Source Link</a>\n\n</div>\n","source":"seekingalpha_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SMXT, ANVS and IFBD among pre-market losers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSMXT, ANVS and IFBD among pre-market losers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-28 21:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4072977-smxt-anvs-and-ifbd-among-pre-market-losers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. ...</p>\n\n<a href=\"https://seekingalpha.com/news/4072977-smxt-anvs-and-ifbd-among-pre-market-losers\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1429558221.USD","symbol_name":"Natixis Loomis Sayles US Growth Equity RA USD","start_time":0,"source_url":"https://seekingalpha.com/news/4072977-smxt-anvs-and-ifbd-among-pre-market-losers","article_id":"2414432421","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2414432421","pubTimestamp":1709126744,"columns":[],"sourceInfo":{"source_id":"seekingalpha_hot_news","name":"SeekingAlpha"},"weMediaInfo":null,"summary":"Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","BK4138":"石油与天然气的炼制和营销","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","BMBL":"Bumble Inc.","OPK":"Opko Health","HTOO":"Fusion Fuel Green PLC","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","BK4562":"SPAC上市公司","LU0082616367.USD":"摩根大通美国科技A（dist）","DV":"DoubleVerify Holdings, Inc.","BTOG":"Bit Origin","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","BK4564":"太空概念","PAYO":"Payoneer Global Inc.","LAZR":"Luminar Technologies, Inc.","BK4204":"教育服务","AMST":"Amesite Inc.","NVAX":"诺瓦瓦克斯医药","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4585":"ETF&股票定投概念","BK4139":"生物科技","SPCE":"维珍银河","BK4566":"资本集团","IAS":"Integral Ad Science Holding","VTNR":"顶点能源","BK4196":"保健护理服务","BK4009":"广告","CLLS":"Cellectis S.A.","BK4587":"ChatGPT概念","BK4535":"淡马锡持仓","LMND":"Lemonade, Inc.","BK4077":"互动媒体与服务","BK4568":"美国抗疫概念","BK4537":"激光雷达概念","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","NFLX":"奈飞","ANVS":"Annovis Bio, Inc.","BK4551":"寇图资本持仓","RXRX":"Recursion Pharmaceuticals, Inc.","IFBD":"讯鸟软件","DDD":"3D系统","BK4096":"电气部件与设备","AIRE":"reAlpha Tech Corp.","SMXT":"SolarMax Technology","PTN":"Palatin Technologies Inc","OGEN":"Oragenics Inc."},"translate_title":"SMXT、ANVS和IFBD是盘前输家","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1,"BMBL":1,"BTOG":1,"CLLS":1,"DDD":1,"AIRE":1,"HTOO":1,"IAS":1,"IFBD":1,"LAZR":1,"LMND":1,"DV":1,"OGEN":1,"OPK":1,"PAYO":1,"PTN":1,"RXRX":1,"SMXT":1,"SPCE":1,"STRC":1,"VTNR":1,"AMST":1,"ANVS":1,"NFLX":0.61},"content_text":"Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. Integral Ad Science Holding Corp (IAS) -26% after Q4 earnings release. Novavax (NVAX) -19% reports fourth Quarter and full year 2023 financial results and operational highlights.  SolarMax Technology (SMXT) -18%. 3D Systems Corp. (DDD) -17% after Q4 earnings release. Vertex Energy (VTNR) -17% reports Q4 results. Lemonade (LMND) -16% after Q4 earnings release. DoubleVerify Holdings (DV) -14%. Sarcos Technology and Robotics Corporation (STRC) -14%. Payoneer Global (PAYO) -13% after Q4 earnings release. Annovis Bio (ANVS) -12%. Amesite (AMST) -12%. Bumble (BMBL) -12% after Q4 earnings release. Recursion Pharmaceuticals (RXRX) -11% after Q4 earnings release. Luminar Technologies (LAZR) -10% after Q4 earnings release. Infobird Co Ltd (IFBD) -9%. Cellectis (CLLS) -7%. Virgin Galactic Holdings (SPCE) -7% after Q4 earnings release. Bit Origin Ltd (BTOG) -7%. Fusion Fuel Green Ltd (HTOO) -6%. reAlpha Tech Corp. (AIRE) -5%. Opko Health (OPK) -6% after Q4 earnings release.   More on pre-market losers & stocks.  Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects Annovis And Alzheimer's Disease: The Best-Laid Plans Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules Annovis falls 16% on Phase 3 data delay for Parkinson's drug","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2414432421"}